Download PDF
Semin Thromb Hemost 1995; 21(S 04): 034-044
DOI: 10.1055/s-0032-1313619
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Thromboelastography in Liver Transplantation

Yoogoo Kang
Further Information

Publication History

Publication Date:
09 May 2012 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Von Kaulla KN, Kaye H, Von Kaulla E, Marchioro TL, Starzl TE. Changes in blood coagulation, before and after hepatectomy or transplantation in dogs and man. Arch Surg 92: 71-79 1966;
    CrossrefPubMedGoogle Scholar
  • 2 Howland WS, Ryan GM, Bettigole RE, Fortner JG. Coagulation abnormalities associated with liver transplantation. Surgery 68: 591-596 1970;
    PubMedGoogle Scholar
  • 3 Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli BJ, Malatack JJ, Schade RR, Shaw Jr BW, Hakala TR, Rosenthal JT, Porter KA. Evolution of liver transplantation. Hepatology 2: 614-636 1982;
    PubMedGoogle Scholar
  • 4 Kang YG, Martin DJ, Maquez J, Lewis JH, Bontempo FA, Shaw Jr BW, Starzl TE, Winter PM. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 64: 888-896 1985;
    PubMedGoogle Scholar
  • 5 Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 66: 766-773 1987;
    PubMedGoogle Scholar
  • 6 Owen Jr CA, Rettke SR, Bowie EJW, Cole TL, Jensen CC, Wiesner RH, Krom RA. Hemostatic evaluation of patients undergoing liver transplantation. Mayo Clin Proc 62: 761-772 1987;
    CrossrefPubMedGoogle Scholar
  • 7 Ballard HS, Marcus AJ. Platelet aggregation in portal cirrhosis. Arch Intern Med 136: 316-319 1976;
    CrossrefPubMedGoogle Scholar
  • 8 Aster RH. Pooling of platelets in the spleen: Role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest 45: 645-657 1966;
    CrossrefPubMedGoogle Scholar
  • 9 Canoso RT, Hutton RA, Deykin D. The hemostatic defect of chronic liver disease. Gastroenterology 76: 540-547 1979;
    PubMedGoogle Scholar
  • 10 Stein SF, Harker LA. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 99: 217-230 1982;
    PubMedGoogle Scholar
  • 11 Lindenbaum J. Folate and vitamin B12 deficiencies in alcoholism. Semin Hematol 17: 119-129 1980;
    PubMedGoogle Scholar
  • 12 Cowan DH. Effect of alcoholism on hemostasis. Semin Hematol 17: 137-147 1980;
    PubMedGoogle Scholar
  • 13 Owen JS, Hutton RA, Day RC, Bruckdorfer KR, McIntyre N. Platelet lipid composition and platelet aggregation in human liver disease. J Lipid Res 22: 423-430 1981;
    PubMedGoogle Scholar
  • 14 Karpatkin KS, Freedman ML. Hypersplenic thrombocytopenia differentiated from increased peripheral destruction by platelet volume. Ann Intern Med 89: 200-203 1978;
    PubMedGoogle Scholar
  • 15 Martinez J, Palascak JE, Kwasniak D. Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease. J Clin Invest 61: 535-538 1978;
    CrossrefPubMedGoogle Scholar
  • 16 Green G, Thomson JM, Dymock IW, Poller L. Abnormal fibrin polymerisation in liver disease. Br J Haematol 34: 425-439 1976;
    PubMedGoogle Scholar
  • 17 Green AJ, Ratnoff OD. Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver. J Lab Clin Med 83: 189-197 1974;
    PubMedGoogle Scholar
  • 18 Knot EAR, Drijfhout HR, ten Cate JW, De Jong E, Iburg AH, Kahle LH, Grijm R. α2-Antiplasmin inhibitor metabolism in patients with liver cirrhosis. J Lab Clin Med 105: 353-358 1985;
    PubMedGoogle Scholar
  • 19 Saito H, Goodnough LT, Boyle JM, Heimburger N. Reduced histidinerich glycoprotein levels in plasmas of patients with advanced liver cirrhosis: Possible implications for enhanced fibrinolysis. Am J Med 73: 179-182 1982;
    CrossrefPubMedGoogle Scholar
  • 20 Fletcher AP, Biederman O, Moore D, Alkjaersig N, Sherry S. Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: Its cause and consequences. J Clin Invest 43: 681-695 1964;
    CrossrefPubMedGoogle Scholar
  • 21 Tytgat G, Collen D, DeBreker RR, Verstraete M. Investigatious on the fibrinolytic system in liver cirrhosis. Acta Haematol (Basel) 40: 265-274 1968;
    CrossrefPubMedGoogle Scholar
  • 22 Bontempo FA, Lewis JH, Van Thiel DH, Spero JA, Ragni MV, Butler P, Israel L, Starzl TE. The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation 39: 532-536 1985;
    CrossrefPubMedGoogle Scholar
  • 23 Groth CG, Pechet L, Starzl TE. Coagulation during and after orthotopic transplantation of the human liver. Arch Surg 98: 31-34 1969;
    CrossrefPubMedGoogle Scholar
  • 24 Flute PT, Rake MO, Williams R, Seaman MJ, CaIne RY. Liver transplantation in man-IV, haemorrhage and thrombosis. Br Med J 3: 20-23 1969;
    CrossrefPubMedGoogle Scholar
  • 25 Lewis JH, Bontempo FA, Awad SA, Kang YG, Kiss JE, Ragni MV, Spero JA, Starzl TE. Liver transplantation: Intraoperative changes in coagulation factors in 100 first transplants. Hepatology 9: 710-714 1989;
    CrossrefPubMedGoogle Scholar
  • 26 Kratzer MAA, Dieterich J, Denecke H, Knedel M. Hemostatic variables and blood loss during orthotopic human liver transplantation. Transplant Proc 23: 1906-1911 1991;
    PubMedGoogle Scholar
  • 27 Porte RJ, Bontempo FA, Knott EAR, Lewis JH, Kang YG, Starzl TE. Systemic effects of tissue plasminogen activity-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 47: 978-984 1989;
    CrossrefPubMedGoogle Scholar
  • 28 Virji MA, Aggarwal S, Kang Y. Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation. Transplant Proc 21 (Suppl 3) 3540-3541 1989;
    PubMedGoogle Scholar
  • 29 Lewis JH, Bontempo FA, Ragni MV, Starzl TE. Antithrombin III during liver transplantation. Transplant Proc 21: 3543-3544 1989;
    PubMedGoogle Scholar
  • 30 Kang YG. Monitoring and treatment of coagulation. In: Winter PM, Kang YG, (Eds) Hepatic Transplantation: Anesthetic and Perioperative Management. Praeger; New York: 1986: 151-173
    Google Scholar
  • 31 Zuckerman L, Cohen L, Vagher JP, Woodward E, Caprini JA. Comparison of thromboelastography with common coagulation tests. Thromb Haemostas 46: 752-756 1981;
    PubMedGoogle Scholar
  • 32 McNicol GP, Fletcher AP, Alkjaersig N, Sherry S. The absorption, distribution, and excretion of ε-aminocaproic acid following oral or intravenous administration to man. J Lab Clin Med 59: 15-24 1962;
    PubMedGoogle Scholar
  • 33 Rake MO, Flute PT, Parnell G, Williams R. Intravascular coagulation in acute hepatic necrosis. Lancet 1: 533-537 1970;
    PubMedGoogle Scholar
  • 34 Bellani KG, Estrin JA, Ascher NL, Najarian JS, Bushman J, Buckley JJ. Reperfusion coagulopathy during human liver transplantation. Transplant Proc 19 (Suppl 3) 71-72 1987;
    PubMedGoogle Scholar
  • 35 Royston D. Aprotinin prevents bleeding and has effects on platelets and fibrinolysis. J Cardiothorac Anesth 5 (Suppl 1) 18-23 1991;
    PubMedGoogle Scholar
  • 36 Neuhaus P, Bechstein WO, Lefebre B, Blumhardt G, Slama K. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet 2: 924-925 1989;
    PubMedGoogle Scholar
  • 37 Mallett SV, Cox D, Burroughs AK, Rolles K. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation. (Letter.). Lancet 336: 886-887 1990;
    PubMedGoogle Scholar
  • 38 Grosse H, Lobbes W, Frambach M, von Broen O, Ringe B, Barthels M. The use of high dose of aprotinin in liver transplantation: The influence of fibrinolysis and blood loss. Thromb Res 63: 287-297 1991;
    CrossrefPubMedGoogle Scholar
  • 39 Himmelreich G, Kierzek B, Neuhaus P, Siamer KJ, Riess H. Fibrinolytic changes and the influence of the early perfusate in orthotopic liver transplantation with intraoperative aprotinin treatment. Transplant Proc 23: 1936-1937 1991;
    PubMedGoogle Scholar
  • 40 Kang Y, De Wolf AM, Aggarwal S. In vitro study of the effects of aprotinin on coagulation during orthotopic liver transplantation. Transplant Proc 23: 1934-1935 1991;
    PubMedGoogle Scholar
  • 41 Anderson TLG, Solem JO, Tengborn L, Vinge E. Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation 81: 872-878 1990;
    CrossrefPubMedGoogle Scholar
  • 42 Mannucci PM, Vicente V, Vianello L, Cattaneo M, Alberca I, Coccato MP, Faioni E, Mari D. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 67: 1148-1153 1986;
    PubMedGoogle Scholar
  • 43 Mannucci PM. Desmopressin: A nontransfusional form oftreatment for congenital and acquired bleeding disorders. Blood 72: 1449-1455 1988;
    PubMedGoogle Scholar
  • 44 Kang Y, Scott V, DeWolf A, Roskoph J, Aggarwal S. In vitro effects of DDAVP during liver transplantation. Transplant Proc 25: 1821-1822 1993;
    PubMedGoogle Scholar
  • 45 Kang Y, Borland LM, Picone J, Martin LK. Intraoperative coagulation changes in children undergoing liver transplantation. Anesthesiology 71: 44-47 1989;
    CrossrefPubMedGoogle Scholar
  • 46 Starzl TE, Groth CG, Makowka L. Clio Chirurgica: Liver Transplantation. Silvergirl; Austin: 1988: 167
    Google Scholar